Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients...
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today the publication, in the Journal of Clinical Chemistry, of the final results of the multicenter DETECT III clinical...
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today the publication, in the peer-reviewed journal Cancers, of the results of a clinical study on the utility of CTCs to ...
Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, announced today the availability of its new CELLSEARCH CTC lab service to detect expression of the...
Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies, announced today the data from two posters to be presented at the April 14-19, 2023 annual meeting of the...
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the promising long-term results of the STIC trial, on OS (overall survival) in patients with ER+/HER2-...
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the results of a study in which enumeration and genomic characterization of CTCs at varying...
Menarini Silicon Biosystems (MSB), Inc. is announcing that the AMA has issued Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) codes for two of its CELLSEARCH advanced...
Menarini Silicon Biosystems Inc, a US company part of the Menarini Group and DIESSE Diagnostica Senese Società Benefit S.p.A., a company with over 40 years of experience in the world of laboratory...
Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced today its new FFPE Rescue Application, to enable molecular testing on formalin-fixed, paraffin-embedded (FFPE)...
Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies today announced that Dana-Farber Cancer Institute and the Multiple Myeloma Research Foundation presented...
Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies, announced today the commercial launch of its CELLSEARCH® Laboratory Developed Test (LDT) for enumeration of ...
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of the new highly automated DEPArray™ PLUS*, now available with 9 fluorescent channels....
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of a new assay to meet the needs of pharma companies, CROs, clinicians and research...
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of its innovative CellMag product line for the manual enrichment and staining of rare...
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today new data from the DETECT study program. These data focused on women with HER2 negative metastatic breast cancer...
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, today announced the results of a pooled analysis of 14 clinical trials on the relevance of circulating tumor cell (CTC) count to...
Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study providing support for the reliability of using circulating tumor cell (CTC)...
Menarini Silicon Biosystems (MSB), the pioneer of liquid biopsy and rare cell technologies, announced today that it has entered into a strategic co-promotion partnership for its CELLSEARCH...
Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at the virtual 2020 meeting of the American Society of...
Menarini Silicon Biosystems, a global leader in liquid biopsy and rare cells technologies, today announces that it is exploring the possible use of its proprietary CELLSEARCH technology to study the...
Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will host a symposium on the importance of liquid biopsy and circulating tumor cells (CTCs) in advancing...
Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin...
Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT™, a volume reduction instrument optimized to remove manual sample...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.